NO20080433L - Luftveisadministrering av aktivt protein C i inflammatoriske tilstander som pavirker luftveiene - Google Patents
Luftveisadministrering av aktivt protein C i inflammatoriske tilstander som pavirker luftveieneInfo
- Publication number
- NO20080433L NO20080433L NO20080433A NO20080433A NO20080433L NO 20080433 L NO20080433 L NO 20080433L NO 20080433 A NO20080433 A NO 20080433A NO 20080433 A NO20080433 A NO 20080433A NO 20080433 L NO20080433 L NO 20080433L
- Authority
- NO
- Norway
- Prior art keywords
- respiratory tract
- administration
- inflammatory conditions
- active protein
- conditions affecting
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4866—Protein C (3.4.21.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Otolaryngology (AREA)
- Dispersion Chemistry (AREA)
- Zoology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69396805P | 2005-06-24 | 2005-06-24 | |
PCT/IB2006/002773 WO2007012976A2 (en) | 2005-06-24 | 2006-06-23 | Airway administration of activated protein c in inflammatory conditions affecting the respiratory tract |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20080433L true NO20080433L (no) | 2008-03-19 |
Family
ID=37570814
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20080433A NO20080433L (no) | 2005-06-24 | 2008-01-23 | Luftveisadministrering av aktivt protein C i inflammatoriske tilstander som pavirker luftveiene |
NO20080434A NO20080434L (no) | 2005-06-24 | 2008-01-23 | Luftveisadministrering av vevsfaktor veiinhibitorer i inflammatoriske tilstander som pavirker luftveien |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20080434A NO20080434L (no) | 2005-06-24 | 2008-01-23 | Luftveisadministrering av vevsfaktor veiinhibitorer i inflammatoriske tilstander som pavirker luftveien |
Country Status (15)
Country | Link |
---|---|
US (3) | US8088728B2 (de) |
EP (3) | EP1898945B1 (de) |
JP (3) | JP2008543925A (de) |
KR (2) | KR20080074085A (de) |
CN (2) | CN101262879B (de) |
AU (2) | AU2006273696B2 (de) |
BR (2) | BRPI0613137A2 (de) |
CA (2) | CA2612646C (de) |
DK (3) | DK1898945T3 (de) |
HK (1) | HK1114567A1 (de) |
IL (2) | IL188220A0 (de) |
NO (2) | NO20080433L (de) |
RU (2) | RU2496516C2 (de) |
WO (3) | WO2006136963A2 (de) |
ZA (2) | ZA200800255B (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008071197A1 (en) * | 2006-12-11 | 2008-06-19 | Drugrecure Aps | Methods for treating cystic fibrosis or pneumonia with bacterial infection via pulmonary administration of fosfomycin |
JP6273272B2 (ja) | 2012-07-04 | 2018-01-31 | ジージー バイオテック エルエルシー | 炎症性皮膚障害の治療 |
PL3137102T3 (pl) | 2014-04-16 | 2022-02-07 | Zz Biotech Llc | Apc do stosowania w leczeniu nieprawidłowego bliznowacenia skóry |
US20190269765A1 (en) * | 2016-09-13 | 2019-09-05 | Prothera Biologics, Inc. | Methods for treating pulmonary disease using inter-alpha inhibitor proteins |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
US4501728A (en) * | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
US4775624A (en) * | 1985-02-08 | 1988-10-04 | Eli Lilly And Company | Vectors and compounds for expression of human protein C |
GR860984B (en) * | 1985-04-17 | 1986-08-18 | Zymogenetics Inc | Expression of factor vii and ix activities in mammalian cells |
US4837028A (en) * | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
US5106833A (en) | 1987-07-23 | 1992-04-21 | Washington University | Coagulation inhibitors |
US4966852A (en) | 1987-07-23 | 1990-10-30 | Monsanto Company | DNA clone of human tissue factor inhibitor |
US4992373A (en) * | 1987-12-04 | 1991-02-12 | Eli Lilly And Company | Vectors and compounds for direct expression of activated human protein C |
US6013619A (en) * | 1988-01-06 | 2000-01-11 | The Scripps Research Institute | Pulmonary surfactants and therapeutic uses, including pulmonary lavage |
US4981952A (en) * | 1988-10-04 | 1991-01-01 | Eli Lilly And Company | Method for the purification of vitamin K-dependent proteins |
DK408089D0 (da) * | 1989-08-18 | 1989-08-18 | Novo Nordisk As | Proteiner |
US5378614A (en) | 1989-08-18 | 1995-01-03 | Novo Nordisk A/S | Vector and method for making tissue factor pathway inhibitor (TFPI) analogues in yeast |
SE9200541D0 (sv) * | 1992-02-24 | 1992-02-24 | Kabi Pharmacia Ab | New usee of omega-3-fatty acids |
US5212091A (en) | 1992-03-02 | 1993-05-18 | Monsanto Company | Method of producing tissue factor pathway inhibitor |
AU730133B2 (en) * | 1996-11-08 | 2001-02-22 | Oklahoma Medical Research Foundation | Modified protein C and methods of use thereof |
US6497877B1 (en) * | 1997-01-29 | 2002-12-24 | University Technology Corporation | Plasminogen activator as an anti-inflammatory agent |
HUP0001237A3 (en) * | 1997-10-20 | 2002-01-28 | Lilly Co Eli | Methods for treating vascular disorders |
US6049577A (en) * | 1998-05-28 | 2000-04-11 | Glenayre Electronics, Inc. | Header synchronization detector |
AR023819A1 (es) * | 1999-05-03 | 2002-09-04 | Astrazeneca Ab | FORMULACIoN FARMACEUTICA, KIT DE PARTES Y UTILIZACION DE DICHA FORMULACION |
JP4848092B2 (ja) * | 2000-02-01 | 2011-12-28 | 石原産業株式会社 | ジアミノトリフルオロメチルピリジン誘導体を含有する肺不全の治療剤又は予防剤 |
ES2234807T3 (es) * | 2000-02-02 | 2005-07-01 | Eli Lilly And Company | Derivados de proteina c. |
DK1257295T3 (da) * | 2000-02-11 | 2009-08-10 | Bayer Healthcare Llc | Faktor VII eller VIIA-lignende molekyler |
US6933367B2 (en) * | 2000-10-18 | 2005-08-23 | Maxygen Aps | Protein C or activated protein C-like molecules |
RU2003134701A (ru) * | 2001-05-02 | 2005-03-27 | Ново Нордиск А/С (DK) | Модифицированный fvii при лечении ards |
DE10132307A1 (de) * | 2001-07-06 | 2003-01-30 | Aventis Behring Gmbh | Arzneizubereitung zur Inhalation von Antithrombin bei entzündlichen Lungenerkrankungen und ARDS |
BR0213292A (pt) * | 2001-10-15 | 2006-05-23 | Chiron Corp | tratamento de pneumonia severa por administração de inibidor da via de fator tecidual (tfpi) |
JP4229840B2 (ja) * | 2002-02-08 | 2009-02-25 | エスケー エナジー 株式会社 | ヒーターチューブの洗浄のための洗浄剤および方法 |
WO2003090682A2 (en) * | 2002-04-25 | 2003-11-06 | The Scripps Research Institute | Treatment and prevention of pulmonary conditions |
ATE424215T1 (de) * | 2003-01-08 | 2009-03-15 | Novartis Vaccines & Diagnostic | Stabilisierte wässrige zusammensetzungen mit gewebefaktorinhibitor (tfpi) oder gewebefaktorinhibitor-variante |
JPWO2004087148A1 (ja) * | 2003-03-31 | 2006-06-29 | 協和醗酵工業株式会社 | 肺疾患の治療および/または予防剤 |
WO2005042011A1 (en) * | 2003-11-04 | 2005-05-12 | Novo Nordisk A/S | Pharmaceutical composition comprising a protein c polypeptide and a blood glucose regulator |
MX2007002903A (es) * | 2004-09-10 | 2007-07-11 | Pharmaorigin Aps | Metodos para el tratamiento de hemoptisis o hemorragias traqueales, bronquiales o alveolares, locales. |
US8563511B2 (en) | 2004-10-06 | 2013-10-22 | University Of Rochester | Treatment of pulmonary hypertension using an agent that inhibits a tissue factor pathway |
-
2006
- 2006-06-23 AU AU2006273696A patent/AU2006273696B2/en not_active Ceased
- 2006-06-23 KR KR1020087001975A patent/KR20080074085A/ko not_active Application Discontinuation
- 2006-06-23 WO PCT/IB2006/002631 patent/WO2006136963A2/en active Application Filing
- 2006-06-23 CN CN2006800310622A patent/CN101262879B/zh not_active Expired - Fee Related
- 2006-06-23 CA CA2612646A patent/CA2612646C/en not_active Expired - Fee Related
- 2006-06-23 EP EP06795540A patent/EP1898945B1/de active Active
- 2006-06-23 JP JP2008517629A patent/JP2008543925A/ja active Pending
- 2006-06-23 US US11/993,253 patent/US8088728B2/en not_active Expired - Fee Related
- 2006-06-23 US US11/993,256 patent/US20100297099A1/en not_active Abandoned
- 2006-06-23 EP EP06808954.9A patent/EP1906994B1/de active Active
- 2006-06-23 ZA ZA200800255A patent/ZA200800255B/xx unknown
- 2006-06-23 US US11/993,264 patent/US20100279925A1/en not_active Abandoned
- 2006-06-23 KR KR1020087001976A patent/KR20080071116A/ko not_active Application Discontinuation
- 2006-06-23 ZA ZA200800251A patent/ZA200800251B/xx unknown
- 2006-06-23 DK DK06795540.1T patent/DK1898945T3/da active
- 2006-06-23 JP JP2008517630A patent/JP2008543926A/ja active Pending
- 2006-06-23 RU RU2008102655/15A patent/RU2496516C2/ru not_active IP Right Cessation
- 2006-06-23 CA CA2612597A patent/CA2612597C/en not_active Expired - Fee Related
- 2006-06-23 BR BRPI0613137-9A patent/BRPI0613137A2/pt not_active Application Discontinuation
- 2006-06-23 DK DK06808954.9T patent/DK1906994T3/da active
- 2006-06-23 AU AU2006260599A patent/AU2006260599A1/en not_active Abandoned
- 2006-06-23 RU RU2008102656/15A patent/RU2496515C2/ru not_active IP Right Cessation
- 2006-06-23 DK DK06795527.8T patent/DK1896059T3/da active
- 2006-06-23 EP EP06795527A patent/EP1896059B1/de active Active
- 2006-06-23 WO PCT/IB2006/002602 patent/WO2006136962A2/en active Application Filing
- 2006-06-23 CN CNA2006800310726A patent/CN101262880A/zh active Pending
- 2006-06-23 BR BRPI0611710-4A patent/BRPI0611710A2/pt not_active Application Discontinuation
- 2006-06-23 WO PCT/IB2006/002773 patent/WO2007012976A2/en active Application Filing
-
2007
- 2007-12-18 IL IL188220A patent/IL188220A0/en unknown
- 2007-12-18 IL IL188221A patent/IL188221A0/en unknown
-
2008
- 2008-01-23 NO NO20080433A patent/NO20080433L/no unknown
- 2008-01-23 NO NO20080434A patent/NO20080434L/no unknown
- 2008-09-11 HK HK08110145.5A patent/HK1114567A1/xx not_active IP Right Cessation
-
2013
- 2013-02-27 JP JP2013037700A patent/JP2013151510A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Chignalia et al. | The glycocalyx and trauma: a review | |
Matthay et al. | The acute respiratory distress syndrome | |
NO20080433L (no) | Luftveisadministrering av aktivt protein C i inflammatoriske tilstander som pavirker luftveiene | |
NO20075077L (no) | Fremgangsmate for a forbedre laering og hukommelse i pattedyr | |
NO20065232L (no) | 8-(2-hydroksyfenoksy)oktyldietanolamin og salter derav for avlevering av aktive forbindelser | |
Wösten-van Asperen et al. | ACE mediates ventilator-induced lung injury in rats via angiotensin II but not bradykinin | |
DK1718336T3 (da) | Ny kombination af anticholinergikum og beta-mimetika til behandling af luftvejssygdomme | |
NO20072466L (no) | Fremgangsmate for a forhindre og behandle strukturendring i luftveier og pulmonal inflammasjon ved a anvende A2B-adenosinreseptorantagonister | |
ATE516285T1 (de) | Dihydropyridinonderivate | |
EA201290374A1 (ru) | Аэрозольная композиция для copd | |
Brunini et al. | Inhibition of l‐arginine transport in platelets by asymmetric dimethylarginine and NG‐monomethyl‐l‐arginine: Effects of arterial hypertension | |
ATE525394T1 (de) | Peptide mit verbesserten eigenschaften mit der biologischen wirkung eines vasoaktiven intestinalen peptids (vip) und ihre verwendung zur behandlung von lungenerkrankung | |
Pilecki et al. | Surfactant protein D deficiency aggravates cigarette smoke-induced lung inflammation by upregulation of ceramide synthesis | |
Kinaneh et al. | Heparanase as a potential player in SARS-CoV-2 infection and induced coagulopathy | |
Wang et al. | Airway epithelial dysfunction in the development of acute lung injury and acute respiratory distress syndrome | |
Lau et al. | Enhanced fibrinolysis protects against lung ischemia–reperfusion injury | |
ATE402190T1 (de) | Surfactant protein d zur vorbeugung und diagnose des lungenemphysems | |
WO2007110698A3 (en) | Methods for inhibiting carcinogenesis and/or metastasis in an individual with endogenous c-met ligands and inhibitors | |
Ge et al. | Complement and complement regulatory proteins are upregulated in lungs of COVID-19 patients | |
JP2009520696A5 (de) | ||
NO20054556L (no) | Amylinaggregeringsinhibitorer og anvendelse derav | |
ATE431755T1 (de) | Filternder abscheider für partikelbelastete gase | |
Chen | Dabigatran etexilate overdose | |
Eapen et al. | M1 And M2 Macrophage Populations In The Airways Of Smokers And COPD Patients: Insights From Both Airway Tissue And Lumen | |
Stampfli et al. | Prostaglandin E2 Attenuates Cigarette Smoke-Induced Cellular Inflammation In A Socs3-Independent Manner |